Reduction in Staphylococcus aureus bacteraemia rates in patients receiving haemodialysis following alteration of skin antisepsis procedures

BJ Stewart, T Gardiner, Greg J Perry, Steven Tong

    Research output: Contribution to journalArticle

    Abstract

    This study examined all cases of Staphylococcus aureus bacteraemia (SAB) in the haemodialysis cohort at the Royal Darwin Hospital, Australia over a seven-year period. Midway through this period, antisepsis for arteriovenous fistulae (AVF) and central venous catheters (CVC) changed from 0.5% chlorhexidine solution to 2% chlorhexidine solution. Rates of SAB episodes were calculated using registry data. Trends in SAB over time were analysed using an interrupted regression analysis. Following the change to 2% chlorhexidine, average SAB rates decreased by 68%, and it is estimated that 0.111 cases of SAB/patient-year were prevented. CVC-related SAB rates remained low throughout. These results support the use of 2% chlorhexidine in skin antisepsis for patients with AVF. � 2015 The Healthcare Infection Society.
    Original languageEnglish
    Pages (from-to)191-193
    Number of pages3
    JournalJournal of Hospital Infection
    Volume92
    Issue number2
    DOIs
    Publication statusPublished - 2016

    Fingerprint Dive into the research topics of 'Reduction in Staphylococcus aureus bacteraemia rates in patients receiving haemodialysis following alteration of skin antisepsis procedures'. Together they form a unique fingerprint.

  • Cite this